Rankings
▼
Calendar
ALGS Q1 2021 Earnings — Aligos Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ALGS
Aligos Therapeutics, Inc.
$45M
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$910,000
Gross Profit
$910,000
100.0% margin
Operating Income
-$28M
-3048.4% margin
Net Income
-$28M
-3041.1% margin
EPS (Diluted)
$-0.74
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$30M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$235M
Total Liabilities
$39M
Stockholders' Equity
$195M
Cash & Equivalents
$200M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$910,000
$0
—
Gross Profit
$910,000
$0
—
Operating Income
-$28M
-$21M
-33.9%
Net Income
-$28M
-$20M
-38.2%
← FY 2021
All Quarters
Q2 2021 →